UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

: Alburex-200g-L-Solution-SE-AJ-RA - JSON Representation

Raw json | Download


{
  "resourceType" : "RegulatedAuthorization",
  "id" : "Alburex-200g-L-Solution-SE-AJ-RA",
  "meta" : {
    "profile" : [
      🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: RegulatedAuthorization Alburex-200g-L-Solution-SE-AJ-RA</b></p><a name=\"Alburex-200g-L-Solution-SE-AJ-RA\"> </a><a name=\"hcAlburex-200g-L-Solution-SE-AJ-RA\"> </a><a name=\"hcAlburex-200g-L-Solution-SE-AJ-RA-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/marketingAuthorizationNumber</code>/50243</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-Alburex-200g-L-Solution-SE-AJ-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100000398-00050243,http://ema.europa.eu/fhir/eurdId#10836; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = solution for infusion; indication = Återställande och upprätthållande av cirkulerande blodvolym vid volymbrist och när  användning av en kolloid är lämpligt.  Val av albumin istället för en artificiell kolloid kan göras med hänsyn till patientens kliniska  tillstånd och aktuella behandlingsrekommendationer.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = albumin</a></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/220000000060 220000000061}\">Marketing Authorisation</span></p><p><b>region</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></p><p><b>status</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072049 100000072099}\">Valid</span></p><p><b>statusDate</b>: 2014-03-28</p><p><b>holder</b>: <a href=\"Organization-LOC-100004673.html\">Organization CSL Behring GmBH</a></p><h3>Cases</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Date[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://ema.europa.eu/fhir/authorisationDateType dateOfFirstAuthorisation}\">First Authorisation</span></td><td>2014-03-28</td></tr></table></div>"
  },
  "identifier" : [
    {
      "system" : "http://ema.europa.eu/fhir/marketingAuthorizationNumber",
      "value" : "50243"
    }
  ],
  "subject" : [
    {
      🔗 "reference" : "MedicinalProductDefinition/Alburex-200g-L-Solution-SE-AJ-MPD"
    }
  ],
  "type" : {
    "coding" : [
      {
        "system" : "https://spor.ema.europa.eu/v1/lists/220000000060",
        "code" : "220000000061",
        "display" : "Marketing Authorisation"
      }
    ]
  },
  "region" : [
    {
      "coding" : [
        {
          "system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
          "code" : "100000000535",
          "display" : "Kingdom of Sweden"
        }
      ]
    }
  ],
  "status" : {
    "coding" : [
      {
        "system" : "https://spor.ema.europa.eu/v1/lists/100000072049",
        "code" : "100000072099",
        "display" : "Valid"
      }
    ]
  },
  "statusDate" : "2014-03-28",
  "holder" : {
    🔗 "reference" : "Organization/LOC-100004673"
  },
  "case" : {
    "type" : {
      "coding" : [
        {
          "system" : "https://ema.europa.eu/fhir/authorisationDateType",
          "code" : "dateOfFirstAuthorisation",
          "display" : "First Authorisation"
        }
      ]
    },
    "dateDateTime" : "2014-03-28"
  }
}